معرفی
Alec Kimmelman, MD, PhD, is a Professor and Chair of the Department of Radiation Oncology at NYU Grossman School of Medicine, where he also serves as Director of the Laura and Isaac Perlmutter Cancer Center. His clinical focus includes treating gastrointestinal cancers (pancreatic, esophageal, stomach, rectal, and anal) with advanced radiation therapies.
Research Interests: Dr. Kimmelman leads NIH-funded research on pancreatic cancer biology, emphasizing its unique metabolism to identify therapeutic targets. His work connects cancer metabolism to clinical trial design and leverages AI for tumor microenvironment analysis, particularly in epithelial-mesenchymal transition and fibroblast interactions.
Publication Trends: Recent works span
- Microbiota-driven chemotherapy resistance in pancreatic cancer
- Genetic underpinn't of ductal adenocarcinoma
- AI-driven insights into fibroblast-cancer cell interactions
Scientific Awards:
- Elected member, American Society for Clinical Investigation
- Ruth Leff Siegel Award for pancreatic cancer research
Leadership & Grants: As a NIH-funded investigator for over 15 years, Dr. Kimmelman bridges lab discoveries with clinical trials. His editorial roles in journals like Nature, Science, and Cell highlight his influence in cancer research.
